Regular Article THROMBOSIS AND HEMOSTASIS Factors that predict thrombosis in relatives of patients with venous thromboembolism

نویسندگان

  • Francis Couturaud
  • Christophe Leroyer
  • Cecile Tromeur
  • Jim A. Julian
  • Susan R. Kahn
  • Jeffrey S. Ginsberg
  • Philip S. Wells
  • James D. Douketis
  • Dominique Mottier
  • Clive Kearon
چکیده

Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Department of Internal Medicine and Chest Diseases, and Centre d’Investigation Clinique INSERM 0502, Groupe d’Investigation et de Recherche Clinique, Brittany University of Brest, Brest, France; McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada; McGill University, Montreal, QC, Canada; and Department of Medicine University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Venous thromboembolism prophylaxis in critically ill patients.

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is recognized as a common complication in critically ill patients. Risk factors including critical illness, mechanical ventilation, sedative medications, and central venous catheter insertion are major contributing factors to the high risk of VTE. Because of their impaired cardiopulmonary reserve, PE...

متن کامل

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Factor V Leiden (FVLeiden) and prothrombin G20210A are the most common genetic causes of thrombophilia and established risk factors for different clinical manifestations of venous thromboembolism (VTE). This study investigated whether the clinical manifestation of VTE, the extension of deep vein thrombosis (DVT) and the presence of transient risk factors at the time of the first VTE, differed a...

متن کامل

Benefits and risks of preventing thromboembolism with enoxaparin in patients with general surgery in real world--the CLEVER study.

BACKGROUND We aimed to document enoxaparin use in real world and identify the risk factors for bleeding complications. METHODS Postauthorization study in 448 surgical patients receiving enoxaparin prophylaxis. Complete compression ultrasound (CCUS) was performed at day 10 ± 3. RESULTS During treatment, 11 of 448 patients had suspected deep venous thrombosis (DVT) but none confirmed. One pat...

متن کامل

Prospective, non-interventional study on the real-world use of certoparin in daily practice--the PROMEMBER study.

BACKGROUND We aimed to verify safety and effectiveness of certoparin real-world use and to identify predictors of thromboembolic events or bleeding. METHODS This was a non-interventional study documenting patients at hospital- or office-based physicians. RESULTS Patients' (n = 1407) mean age was 53.7 ± 16.1 years. Reason for certoparin use was prophylaxis of venous thromboembolism in 1331 (...

متن کامل

Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis.

Thrombosis occurs most often as myocardial infarction, cerebral infarction or venous thromboembolism, ie, deep-vein thrombosis and pulmonary embolism. The incidence of all types of thrombosis is strongly dependent on age. Among young individuals, up to age 40, venous thrombosis is the most common form of thrombosis. The risk factors for arterial and venous thrombosis differ, and among the latte...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014